Zhang et al. [94] found that acetazolamide (SIRT1), a NAD+-dependent histone deacetylase, exerts antioncogenic effects in HCC through the AMPK-mTOR pathway in the context of mutant p53. Here, MTOR is linked to hepatocellular carcinoma.